Self-expandable metallic stent (SEMS)

DEVICE4 trials

Sponsors

The University of Tokyo, Hospital Universitari de Bellvitge

Conditions

Biliary Tract NeoplasmsInoperable malignant gastrointestinal strictureMalignant Biliary ObstructionPancreatic CancerPancreatic Cancer Resectable

Unknown Phase

Efficacy of gastrointestinal stent (Niti-S Stent) in the malignant gastrointestinal stricture

RecruitingJPRN-UMIN000004566

The University of TokyoInoperable malignant gastrointestinal stricture

Start: 2006-03-01Target: 50Updated: 2026-06-29

EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)

Not yet recruitingNCT06375954

Hospital Universitari de BellvitgeBiliary Tract Neoplasms, Malignant Biliary Obstruction, Pancreatic Cancer

Start: 2024-05-01End: 2027-05-01Target: 96Updated: 2024-04-19

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial)

Not yet recruitingNCT06375928

Hospital Universitari de BellvitgeBiliary Tract Neoplasms, Malignant Biliary Obstruction, Pancreatic Cancer Resectable

Start: 2024-05-01End: 2026-05-01Target: 44Updated: 2024-04-19

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)

SuspendedNCT06653192

Hospital Universitari de BellvitgeBiliary Tract Neoplasms, Malignant Biliary Obstruction, Pancreatic Cancer

Start: 2025-05-06End: 2028-05-06Target: 120Updated: 2026-05-06

Related Papers

Management of malignant gastric outlet obstruction with a modified triple-layer covered metal stent.

2012-01-2834 citations